POLARITYTE, INC. (NASDAQ:COOL) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

0

POLARITYTE, INC. (NASDAQ:COOL) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02

On August 21, 2019, the Company reached a settlement with Dr. Denver Lough resolving Dr. Lough’s status with the Company, which was reported in the Company’s current report on Form 8-K filed with the Securities and Exchange Commission on August 26, 2019. The terms of the settlement include, among other items, the requirement that Dr. Jon Mogford will agree to resign as a director on or before July 31, 2020. to that term of the settlement Dr. Mogford resigned as a director of the Company on July 29, 2020.

99.1 Press release issued July 29, 2020, titled “PolarityTE Announces the Addition of Clinical Development and Regulatory Affairs Executive Jessica Chen, MD, MS, to Board of Directors.”


POLARITYTE, INC. Exhibit
EX-99.1 2 ex99-1.htm   Exhibit 99.1       PolarityTE Announces the Addition of Clinical Development and Regulatory Affairs Executive Jessica Shen,…
To view the full exhibit click here

About POLARITYTE, INC. (NASDAQ:COOL)

PolarityTE, Inc., formerly Majesco Entertainment Company, is a technology company. The Company has developed, marketed, published and distributed software through online platforms. The Company develops applications for gaming on computers, handheld devices and game consoles. The Company is the owner of patent applications and know-how related to regenerative medicine and tissue engineering, as well as software applications used in diagnosis and treatment related to regenerative medicine. It seeks to develop and obtain regulatory approval for technology that will utilize a patient’s own tissue substrates for the regeneration of skin, bone, muscle, cartilage, fat, blood vessels and nerves. Its PolarityTE platform simplifies regeneration and allows cells to function naturally. The platform can be applied across all cells, tissues and composite structures. Its platform induces cell and tissue polarity, and creates functional tissue that mirrors natural development in the human body.